PAWR anticorps
Aperçu rapide pour PAWR anticorps (ABIN2460368)
Antigène
Voir toutes PAWR AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Purification
- Antibody is purified by peptide affinity chromatography method.
-
Immunogène
- Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human PAWR.
-
-
-
-
Indications d'application
- PAWR antibody can be used for detection of PAWR by ELISA at 1:62500. PAWR antibody can be used for detection of PAWR by western blot at 0.2-5.0 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 50 ?L of distilled water. Final antibody concentration is 1 mg/mL.
-
Concentration
- 1 mg/mL
-
Buffer
- Antibody is lyophilized in PBS buffer with 2 % sucrose.
-
Conseil sur la manipulation
- As with any antibody avoid repeat freeze-thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- For short periods of storage (days) store at 4 °C. For longer periods of storage, store PAWR antibody at -20 °C.
-
-
- PAWR (PRKC, Apoptosis, WT1, Regulator (PAWR))
-
Autre désignation
- PAWR
-
Sujet
- The tumor suppressor WT1 represses and activates transcription. Anti-Prostate Apoptosis Response Protein Par-4 (PAWR) is a WT1-interacting protein that itself functions as a transcriptional repressor. It contains a putative leucine zipper domain which interacts with the zinc finger DNA binding domain of WT1. This protein is specifically upregulated during apoptosis of prostate cells.
-
Poids moléculaire
- 37 kDa
-
ID gène
- 5074
-
NCBI Accession
- NP_002574
-
UniProt
- O75796
Antigène
-